Patents for C07F 5 - Compounds containing elements of the 3rd group of the periodic system (13,801)
02/2009
02/19/2009WO2009021947A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri)
02/19/2009US20090047692 Optically-detectable enzyme substrates and their method of use
02/19/2009DE202008013315U1 Lanthanidchelate Lanthanide chelates
02/19/2009DE202008013314U1 Lanthanidchelate Lanthanide chelates
02/19/2009DE102007038930A1 Neue chemische Verbindung und deren Verwendung in der Medizin, insbesondere für die Verwendung in der Tumortherapie Novel chemical compound and its use in medicine, particularly for use in tumor therapy
02/19/2009DE102007036998A1 Verfahren zur Herstellung von amorphen metallorganischen Makromolekülen, mit diesem Verfahren erhaltenes Material und seine Verwendung A process for the preparation of amorphous metal organic macromolecules, obtained by this process material and its use
02/18/2009EP2025679A2 [3.2.0] Heterocyclic compounds and methods of using the same
02/18/2009EP2024310A1 Materials for organic electroluminescent devices
02/18/2009EP2024117A1 Functional nanomaterials with antibacterial and antiviral activity
02/18/2009EP1658255B1 Proteasome inhibitors and methods of using the same
02/18/2009EP1501879B1 Method for anionic polymerisation
02/18/2009CN101368005A Functional rareearth complexes long-life fluorochrome, synthesis and uses thereof
02/18/2009CN101367826A Linking type Eu3+ organic conjunction, its copolymer red luminescent material and method of preparing the same
02/18/2009CN101367825A Double-carbene clamp type rareearth complexes, preparation method and uses of the same in cis-1,4 selective polymerization of diolefin
02/18/2009CN100462358C Aluminum chelate complex for organic EL material
02/17/2009US7491672 Chemically-modified supports and supported catalyst systems prepared therefrom
02/12/2009WO2009020448A1 Proteasome inhibitors
02/12/2009WO2009019234A1 Method for producing amorphous metal organic macromolecules, material obtained by said method, and use thereof
02/12/2009WO2009019100A1 Method for preparing a solution of a rare-earth organophosphate in an organic solvent
02/12/2009WO2007134169A3 Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
02/12/2009US20090042836 Proteasome inhibitors
02/12/2009DE202008013313U1 Markierungsreagenzien Labeling reagents
02/12/2009DE202008013312U1 Markierungsreagenzien Labeling reagents
02/12/2009CA2695082A1 Peptide boronic acid and boronic ester compounds as proteasome inhibitors
02/11/2009EP2022794A1 Fluorescent compound and labeling agent comprising the same
02/11/2009CN101362773A Heterocyclic boronic acid compounds
02/05/2009WO2009018506A1 Processes for making catalyst activators
02/05/2009US20090036628 Oxonium and sulfonium salts
02/05/2009US20090036622 High Bandgap Arylene Polymers
02/05/2009US20090036537 Aromatic triamide-lanthanide complexes
02/05/2009US20090036417 Cochleates without metal cations as bridging agents
02/04/2009EP1494584A4 Endohedral metallofullerene contrast agents
02/04/2009CN101360713A 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides
02/04/2009CN101358128A Rare-earth organic complex light conversion agent and method of preparing the same
02/04/2009CN100457113C Preparation method of bacteriostatic agent sulfadiazine cerium
02/03/2009US7485725 Substituted pyridines
02/03/2009US7485283 imaging myocardial perfusion, comprising administering to a patient a contrast agent which comprises a compound that binds MC-1, and an imaging moiety, and scanning the patient using diagnostic imaging.
01/2009
01/29/2009WO2009014550A1 System for controlling the reactivity of boronic acids
01/29/2009WO2009013553A1 Method for recovering diphenylprolinol type catalysts with phase-tag groups, new catalysts recoverable by this method and their use
01/29/2009WO2009012596A1 Substituted aryl-fluoroborates as imaging agents
01/29/2009WO2008070733A3 Macrocyclic hepatitis c serine protease inhibitors and uses therefor
01/29/2009US20090030238 System for controlling the reactivity of boronic acids
01/29/2009US20090030220 Transparent desiccating agent
01/29/2009US20090030172 Polymeric salen compounds and methods thereof
01/29/2009US20090029945 Non-Anilinic Derivatives of Isothiazol-3(2H)-Thione 1,1-Dioxides As Liver X Receptor Modulators
01/29/2009CA2731645A1 Substituted aryl-fluoroborates as imaging agents
01/29/2009CA2694068A1 System for controlling the reactivity of boronic acids
01/28/2009EP2018365A1 New materials for lithographic plates coatings, lithographic plates and coatings containing same, methods of preparation and use
01/28/2009EP1799692B1 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof
01/28/2009EP1768988B1 Novel phenyl-boronic acid derivatives and methods for the preparation thereof
01/28/2009CN101356179A Lipase inhibitors
01/27/2009US7482451 Emissive phosphorescent organometallic compounds that produce electroluminescence; for use in organic light emitting devices
01/22/2009US20090023928 Phthalamide-lanthanide complexes for use as luminescent markers
01/22/2009US20090022668 Mri contrast agents endowed with concentration independent responsiveness
01/22/2009US20090021160 Material for organic electroluminescent device, method for producing same and organic electroluminescent device
01/21/2009EP2017280A1 Metallocene complex and polymerization catalyst composition containing the same
01/21/2009EP2015757A2 Hydrolytically-resistant boron-containing therapeutics and methods of use
01/21/2009EP1578706B1 Manufacture of trialkylaluminum compounds and alpha-alcohols
01/21/2009CN101348505A Process for preparing cobalt boracylate by hybrid reaction of cobaltous carbonate and organic carboxyl acid
01/21/2009CN101348499A Method of preparing organometallic compounds
01/21/2009CN101348468A P-isosulfhydryl phenyl five-membered nitrogen heterocyclic ring tetraacethyl chelate and preparation thereof
01/20/2009US7479568 Process for making alkaline earth metal borated sulfonates
01/20/2009CA2502856C Intermediates for retroviral protease inhibiting compounds
01/15/2009US20090018357 Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use
01/15/2009US20090018334 Chiral inorganic-organic composite porous material and method for preparing the same
01/15/2009US20090018290 Preparation of Supported Silyl-Capped Silica-Bound Anion Activators and Associated Catalysts
01/15/2009US20090018104 Triarylcarboxylic Acid Derivative
01/15/2009US20090014340 Devices, systems, and methods for measuring glucose
01/15/2009CA2692758A1 A crystalline synthetic intermediate for preparation of a dpp-iv inhibitor and method of purification thereof
01/14/2009EP2013220A1 Method for the production of boronic acids carrying cyanoalkyl, carboxyl and aminocarbonyl groups and their derivatives
01/14/2009EP1536843A4 Radiolabeled compounds and liposomes and their methods of making and using the same
01/14/2009EP1509254B1 New agents for magnetic imaging method
01/14/2009EP1391003A4 Non-aqueous electrolyte additive for improving safety and lithium ion secondary battery comprising the same
01/14/2009CN101346388A Tripodal ligands with the coordinating motifs K2-bh2 or K3-BH3 relevant for biomedical applications of organometallic complexes
01/14/2009CN101343283A Equipartition type beta-diketone imidogen rareearth complexes-sec-propyl alcohol system and uses thereof
01/14/2009CN101343235A Tri-(beta-diketone imidogen) rare earth metal complex and uses thereof
01/14/2009CN101343215A Conjugated polymers containing spirobifluorene units and the use thereof
01/13/2009US7476758 excellent inhibitory activity against alpha 4 integrin-mediated cell adhesion; allergic bronchitis, inflammatory bowel disease, rheumatoid arthritis, experimental autoimmune encephalomyelitis
01/08/2009WO2009004986A1 Curing catalyst for organic polymer and moisture-curable composition containing the same
01/08/2009WO2009004350A1 Methods for preparing bortezomib and intermediates used in its manufacture
01/08/2009WO2009004061A1 CRYSTALLINE, COMPLETELY SOLUBLE LITHIUM BIS(OXALATO)BORATE (LiBOB)
01/08/2009WO2009004059A1 Method for producing low-acid lithium borate salts and mixtures of low-acid lithium borate salts and lithium hydride
01/08/2009WO2009003700A1 Luminescent metal complexes for organic electronic devices
01/08/2009US20090012276 Polyhydroxy Hydrogensulfated Trimetallic Nitride Endohedral Metallofullerenes
01/08/2009US20090012144 Optically active 2,5-bisaryl-delta¹ -pyrrolines and their use as pest control agents
01/08/2009US20090012090 Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy
01/08/2009US20090012044 Novel Hiv Protease Inhibitors
01/08/2009DE102008040154A1 Kristallines, klarlösliches Lithiumbis(oxalato)borat (LiBOB) Crystalline, clear solution of lithium bis (oxalato) borate (LiBOB)
01/08/2009DE102008040153A1 Verfahren zur Herstellung säurearmer Lithiumboratsalze und Mischungen aus säurearmen Lithiumboratsalzen und Lithiumhydrid A process for producing low acid lithium borate salts and mixtures of low-acid lithium borate salts and lithium hydride
01/07/2009EP2010502A1 Pyrimidine derivatives for the treatment of amyloid-related diseases
01/07/2009CN101341119A Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure
01/06/2009CA2371818C Salicylamide-lanthanide complexes for use as luminescent markers
01/01/2009US20090005545 Methods for purifying radiolabelled compounds
01/01/2009US20090004108 Smmr (Small Molecule Metabolite Reporters) For Use As In Vivo Glucose Biosensors
12/2008
12/31/2008WO2009000960A1 Di- and triphenylene-boron dipyrromethene and use thereof as laser colorants in solution and solid state
12/31/2008WO2007100808B1 Method and process for preparing cardiolipin
12/31/2008WO2007100808A4 Method and process for preparing cardiolipin
12/31/2008EP2007743A2 Methods for synthesizing ammonia borane
12/31/2008CN101333226A Chiral dual ring [4.4.0] diborate and method for preparing same
12/31/2008CN100447151C Peptide boronic acids useful in making salts thereof
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 139